A Third of Patients Abandon Breast Cancer Drug Due to Side Effects

Sun, 17 Aug 2025 22:02:48 +0000

Over a third of post-menopausal breast cancer patients who take aromatase inhibitors abandon their treatment, because the drug's side effects are so unbearable, according to researchers from Northwestern University. Aromatase inhibitors are typically given to patients following chemotherapy, radiation therapy, and breast cancer surgery, usually for about 5 years.